Neurophet

Neurophet Intangible Assets

The Intangible Assets of Neurophet (380550.KQ) as of Oct 26, 2026 is 470.29 M KRW. In the previous year, Intangible Assets was 468.45 M KRW — a change of 0.39% (higher).

Intangible Assets

470.29 MKRW

YoY

0.39%

Last updated:

Intangible Assets of Neurophet is 2024 470.29 M KRW. Intangible Assets of Neurophet was 2023 468.45 M KRW. It decreases by 0.39% higher compared to the previous year.

The Neurophet Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2022
415.73 M KRW
Jan 1, 2023
468.45 M KRW
Jan 1, 2024
470.29 M KRW
The Neurophet Intangible Assets history
YEARIntangible AssetsYoY
470.29 MKRW+0.39%
468.45 MKRW+12.68%
415.73 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neurophet Stock analysis

What does Neurophet do? Neurophet Inc generates revenue through the development and sale of brain imaging analysis software, including 'Neurophet SCALE PET' for positron emission tomography (PET) image quantitative analysis and 'Neurophet AQUA' for neurodegenerative brain disease diagnosis support. The company also offers therapeutic medical devices and medical artificial intelligence (AI) solutions. Its primary customers are healthcare providers and medical institutions seeking advanced diagnostic tools and AI-driven healthcare technologies. The products are sold directly to hospitals, clinics, and research institutions that require specialized brain imaging and diagnostic support. Neurophet Inc targets the health care technology sector, focusing on neurology and medical imaging applications. The company's revenue streams include software licensing, device sales, and AI solution subscriptions. Neurophet Inc's business model centers on providing innovative medical technology solutions for neurological conditions. The firm's key products address specific clinical needs in neurodegenerative disease diagnosis and PET image analysis, with a focus on accuracy and efficiency for medical professionals. The company's offerings are designed to enhance diagnostic capabilities in healthcare settings. Neurophet is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neurophet stock

Intangible Assets of Neurophet is 470.29 M KRW in 2024.

Intangible Assets of Neurophet changed from 468.45 M KRW to 470.29 M KRW, representing a 0.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Neurophet since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Neurophet historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Neurophet

All Key Metrics — Neurophet